alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › plasma

plasma

712 studies tagged plasma, dated 1989-01-01 to 2026-11-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Inflammatory biomarker candidates in dementia with Lewy bodies: diagnostic classification, clinical associations, and survival 2026-11-01
  2. Longitudinal plasma biomarkers and multimodal PET across APOE ε4 genotypes: a prospective cohort study 2026-11-01
  3. Concurrent cognitive, behavioral and systemic physiological features mark preclinical Alzheimer's disease 2026-10-30

Studies

712 studies carry this tag.

Date range

1989 to 2026

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 124
  • Journal of Alzheimer's disease : JAD 54
  • Alzheimer's & dementia (Amsterdam, Netherlands) 47
  • Alzheimer's research & therapy 37
  • medRxiv 29

196 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Neurofilament protein in cerebrospinal fluid: a marker of white matter changes

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neuroscience research 2001-11-01 Biomarkers

    The objective of this study was to compare cerebrospinal fluid (CSF) levels of the light subtype of the neurofilament proteins (NFL), tau, and beta-amyloid42 (Abeta42) in individuals with moderate or severe white matter changes (WMC) and in those with mild or no WMC.

  2. Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Journal of Alzheimer's disease : JAD 2000-11 Tau biomarkers

    Potential cerebrospinal fluid (CSF) markers for Alzheimer's disease (AD) include tau protein, the 42 amino-acid form of amyloid beta (amyloid beta(1-42)) and apolipoprotein E (apoE).

  3. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2000-09-01 Drug development

    X-34, a lipophilic, highly fluorescent derivative of Congo red, was examined as a histochemical stain for pathological changes in Alzheimer's disease (AD).

  4. Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Their Role in Clinical Chemistry

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. EJIFCC 2000-03-21 Tau biomarkers

    In view of current (AChE inhibitors) and future (e.g. anti-Aβ aggregators), development and evaluation of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) has become a rapidly growing research field.

  5. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. JAMA 2000-03-01 Brain tissue and pathology

    In this study, levels of total A(beta)x-40 and A(beta)x-42 were elevated early in dementia and levels of both peptides were strongly correlated with cognitive decline.

  6. Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Neuroscience letters 2000-02-18 Tau biomarkers

    Earlier studies have shown elevated levels of tau protein and decreased levels of amyloid beta42 in cerebrospinal fluid (CSF) from patients with Alzheimer's disease (AD).

  7. Longitudinal stability of CSF tau levels in Alzheimer patients

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Biological psychiatry 1999-09-15 Tau biomarkers

    Despite significant changes in the clinical measures consistent with progression of the disease, no significant overall change in CSF tau levels (548 +/- 355 vs. 557 +/- 275 pg/mL, NS) was observed.

  8. Tau protein in cerebrospinal fluid: a new diagnostic and prognostic marker in Alzheimer disease?

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Alzheimer disease and associated disorders 1998-09 Tau biomarkers

    Tau is the main protein of paired helical filaments.

  9. EEG slowing and cerebrospinal fluid tau levels in patients with cognitive decline

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Neuroreport 1998-01-05 Tau biomarkers

    We explored the relationship between cerebrospinal fluid (CSF) tau levels as indirect markers of tau-related pathology in Alzheimer's disease (AD) and EEG slowing, a typical neurophysiological finding in the disease.

  10. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Annals of neurology 1995-10-01 Tau biomarkers

    In this clinical study the cerebrospinal fluid (CSF) level of a novel form of the beta-amyloid peptide (A beta) extending to position 42 (A beta 42) was determined in patients with Alzheimer's disease (AD) as well as controls.

  11. Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Journal of neurology, neurosurgery, and psychiatry 1995-09 Tau biomarkers

    Tau protein concentrations were measured in the CSF of 23 patients with dementia of the Alzheimer type (DAT), 36 patients with multi-infarct dementia (MID), and 23 control subjects.

  12. Tau, paired helical filaments and amyloid in the neocortex: a morphometric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Acta neuropathologica 1989-01-01 Drug development

    Tau immunoreactivity was studied in temporal neocortex, area 22, in 15 cases with graded intellectual status and compared with the immunoreactivity observed with an antiserum against paired helical filaments (PHF) and with the density of amyloid revealed by thioflavin S. Samples came from women over 75 years either intellectually normal or affected by senile dementia of the Alzheimer type at various degrees of severity.

From across this tag

10 of the 710 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

All topic tags with their study counts